Imaging cyclophosphamide-induced intramedullary apoptosis in rats using 99mTc-radiolabeled annexin V.

UNLABELLED Intramedullary apoptosis of hematopoietic tissue is believed to play a major role in the pathophysiology of myelodysplastic syndrome. Annexin V, a specific marker of the early to intermediate phases of apoptosis, has been applied to the in vitro study of bone marrow aspirates. A noninvasive measure of intramedullary apoptosis in vivo that could serially monitor the clinical progression of myelodysplastic syndrome may be helpful. METHODS We used 99mTc-radiolabeled annexin V and radionuclide gamma camera imaging to serially study the sites, extent, and severity of intramedullary apoptosis induced by cyclophosphamide treatment. RESULTS Intravenously administered radiolabeled annexin V localized preferentially in the femur, pelvis, vertebrae, and spleen; increased uptake in these organs was easily visualized as early as 8 h after injection of 100 mg/kg cyclophosphamide in 8- to 10-wk-old animals. Higher doses of cyclophosphamide (150 mg/kg) in animals of the same age increased annexin V uptake in the bone marrow and splenic tissue and delayed recovery of these organs as seen histologically compared with lower doses. Older animals, 5-6 mo old, showed a slower response to cyclophosphamide treatment and delayed recovery of bone marrow and splenic tissues. CONCLUSION Radiolabeled annexin V can be used to detect and directly quantify the degree of intramedullary and splenic apoptosis in a noninvasive fashion using current clinical radionuclide imaging equipment. Annexin V imaging may be useful clinically in the diagnosis and management of myelodysplastic syndrome.

[1]  M. Tavassoli,et al.  Fatty involution of bone marrow in rabbits. , 1984, Acta anatomica.

[2]  H. Handa,et al.  Bone marrow stroma from refractory anemia of myelodysplastic syndrome is defective in its ability to support normal CD34-positive cell proliferation and differentiation in vitro. , 1999, Leukemia research.

[3]  G. Hughes,et al.  The Fanconi anemia group C gene product modulates apoptotic responses to tumor necrosis factor-alpha and Fas ligand but does not suppress expression of receptors of the tumor necrosis factor receptor superfamily. , 1999, Experimental hematology.

[4]  M. Showel,et al.  Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosis , 1999, European journal of haematology.

[5]  P. Venugopal,et al.  Biologic characteristics of patients with hypocellular myelodysplastic syndromes. , 1999, Leukemia research.

[6]  G. Berry,et al.  Radionuclide imaging of acute lung transplant rejection with annexin V. , 2000, Chest.

[7]  H. Gadner,et al.  Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia. , 2000, Blood.

[8]  P. Williamson,et al.  Back and forth: the regulation and function of transbilayer phospholipid movement in eukaryotic cells. , 1994, Molecular membrane biology.

[9]  S. Schrier,et al.  Membrane phospholipid asymmetry in human thalassemia. , 1998, Blood.

[10]  Parker,et al.  ‘Low‐risk’ myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro‐ versus anti‐apoptotic bcl‐2‐related proteins , 1998, British journal of haematology.

[11]  P. Tsoplou,et al.  Apoptosis in patients with myelodysplastic syndromes: differential involvement of marrow cells in ‘good’ versus ‘poor’ prognosis patients and correlation with apoptosis-related genes , 1999, Leukemia.

[12]  C. Schnitzler,et al.  Bone Marrow Composition and Bone Microarchitecture and Turnover in Blacks and Whites , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  A. Schroit,et al.  Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. , 1997, Blood.

[14]  M. Azharuddin,et al.  Sequential activation of caspase-1 and caspase-3-like proteases during apoptosis in myelodysplastic syndromes. , 1999, Journal of hematotherapy & stem cell research.

[15]  G. Mufti,et al.  Apoptosis and its significance in MDS: controversies revisited. , 1999, Leukemia research.

[16]  D. Green,et al.  Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl , 1995, The Journal of experimental medicine.

[17]  T. Tsuruo,et al.  Phosphatidylserine externalization is a downstream event of interleukin-1 beta-converting enzyme family protease activation during apoptosis. , 1997, Blood.

[18]  D. Gibson,et al.  Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. , 1995, Circulation research.

[19]  M. Abrams,et al.  [99mTc]tricine: a useful precursor complex for the radiolabeling of hydrazinonicotinate protein conjugates. , 1995, Bioconjugate chemistry.

[20]  J. Christopher,et al.  Age-related marrow conversion in the proximal metaphysis of the femur: evaluation with T1-weighted MR imaging. , 1998, Radiology.

[21]  A. Karsan,et al.  Apoptotic vascular endothelial cells become procoagulant. , 1997, Blood.

[22]  G. Denardo,et al.  Quo vadis radioimmune imaging? , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  C Haanen,et al.  A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. , 1995, Journal of immunological methods.

[24]  A. Raza,et al.  Is excessive spontaneous intramedullary apoptosis unique to myelodysplasia? , 1998, Experimental hematology.

[25]  C. Reutelingsperger,et al.  The Complexity of the Phospholipid Binding Protein Annexin V , 1995, Thrombosis and Haemostasis.

[26]  S. Sallan,et al.  In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginase. , 1989, Cancer research.

[27]  R. Larsson,et al.  Is in vitro sensitivity of blast cells correlated to therapeutic effect in childhood acute lymphoblastic leukemia? , 1999, Advances in experimental medicine and biology.

[28]  C. Hertzberg,et al.  An electron microscopic study of erythropoiesis in fetal and neonatal rabbits. , 1981, Acta anatomica.

[29]  C. Lacombe,et al.  Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction , 1999, British journal of haematology.

[30]  Gupta,et al.  Increased activity of caspase 3 and caspase 8 in anti‐Fas‐induced apoptosis in lymphocytes from ageing humans , 1999, Clinical and experimental immunology.

[31]  R. Davis,et al.  In vivo detection and imaging of phosphatidylserine expression during programmed cell death. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Cerqueira,et al.  Selective uptake of radiolabeled annexin V on acute porcine left atrial thrombi. , 1995, Circulation.

[33]  F. Blankenberg,et al.  Radiolabeled annexin V imaging: diagnosis of allograft rejection in an experimental rodent model of liver transplantation. , 2000, Radiology.

[34]  D. Gibson,et al.  Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. , 1996, Blood.

[35]  R. Davis,et al.  Imaging of apoptosis (programmed cell death) with 99mTc annexin V. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[36]  B. Hellman,et al.  Demonstration of benzo(a)pyrene-induced DNA damage in mice by alkaline single cell gel electrophoresis: evidence for strand breaks in liver but not in lymphocytes and bone marrow. , 1996, Pharmacology & toxicology.

[37]  J. Tait,et al.  Measurement of phosphatidylserine exposure in leukocytes and platelets by whole-blood flow cytometry with annexin V. , 1999, Blood cells, molecules & diseases.

[38]  E. Anton.  Ultrastructural changes of stromal cells of bone marrow and liver after cyclophosphamide treatment in mice. , 1997, Tissue & cell.

[39]  R. Kratzke,et al.  Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival , 1999, Leukemia.